⌘K

Login Start Free

Home/Filings/4/0001144204-18-050782

4//SEC Filing

MACFARLANE M DAVID 4

Accession 0001144204-18-050782

CIK 0000910267other

View on SEC.gov Company Profile

Filed

Sep 24, 8:00 PM ET

Accepted

Sep 25, 7:09 PM ET

Size

6.7 KB

Accession

0001144204-18-050782

Insider Transaction Report

Form 4

Period: 2018-09-21

TITAN PHARMACEUTICALS INCTTNP.OB

MACFARLANE M DAVID

Director

Transactions

Purchase
Common Stock
2018-09-21$0.25/sh+80,000$20,000→ 102,275 total
Award
Warrants
2018-09-21+80,000→ 80,000 total
Exercise: $0.25From: 2018-09-25Exp: 2023-09-25→ common stock (80,000 underlying)

Documents

1 file

4
tv503429_4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

TITAN PHARMACEUTICALS INC

CIK 0000910267

Entity typeother

Related Parties

1

filerCIK 0001182314

Filing Metadata

Form type: 4
Filed: Sep 24, 8:00 PM ET
Accepted: Sep 25, 7:09 PM ET
Size: 6.7 KB

View on SEC.gov